- Acadia Pharma (ACAD) is scheduled to announce Q4 earnings results on Wednesday, February 25th, after market close.
- The consensus EPS estimate is $0.14 and the consensus revenue estimate is $292.59M (+12.7% Y/Y).
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 4 downward. Revenue estimates have seen 3 upward revisions and 5 downward.
Acadia Pharma Q4 2025 Earnings Preview
